In the context of ICAS, studies have shown associations between low levels of apoA-I and high levels of apoB with the presence and severity of ICAS, indicating their potential as biomarkers for ICAS risk stratification (23, 38). The gene discussed is APOA1; the disease is familial isolated congenital asplenia.